• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Moxifloxacin treatment of tuberculosis.莫西沙星治疗结核病。
Antimicrob Agents Chemother. 2004 Sep;48(9):3642; author reply 3642-3. doi: 10.1128/AAC.48.9.3642-3643.2004.
2
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.莫西沙星治疗肺结核的早期杀菌活性：一项前瞻性随机研究。
Antimicrob Agents Chemother. 2004 Mar;48(3):780-2. doi: 10.1128/AAC.48.3.780-782.2004.
3
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis.莫西沙星与异烟肼联合用药对涂片阳性肺结核的早期杀菌活性
J Antimicrob Chemother. 2005 Dec;56(6):1169-71. doi: 10.1093/jac/dki376. Epub 2005 Oct 13.
4
Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.使用新型盒式系统对莫西沙星治疗结核分枝杆菌感染的体内药代动力学和药效学进行建模。
Antimicrob Agents Chemother. 2005 Feb;49(2):853-6. doi: 10.1128/AAC.49.2.853-856.2005.
5
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.一项关于氧氟沙星、加替沙星和莫西沙星对肺结核杀菌活性的II期研究。
Int J Tuberc Lung Dis. 2008 Feb;12(2):128-38.
6
Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?莫西沙星是否应替代异烟肼作为一线抗结核药物？
Am J Respir Crit Care Med. 2009 Oct 1;180(7):686; author reply 686-7. doi: 10.1164/ajrccm.180.7.686a.
7
Moxifloxacin versus ethambutol in initial tuberculosis treatment.莫西沙星与乙胺丁醇用于初治肺结核的治疗比较
Lancet. 2009 Jun 27;373(9682):2197-8; author reply 2198-9. doi: 10.1016/S0140-6736(09)61188-0.
8
Moxifloxacin versus ethambutol in initial tuberculosis treatment.莫西沙星与乙胺丁醇用于初治结核病的治疗比较
Lancet. 2009 Jun 27;373(9682):2198; author reply 2198-9. doi: 10.1016/S0140-6736(09)61189-2.
9
PanACEA: a new approach to tuberculosis research.泛亚临床试验与评价联盟（PanACEA）：结核病研究的新方法。
Lancet Infect Dis. 2012 Mar;12(3):184-5. doi: 10.1016/s1473-3099(12)70041-5.
10
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.每周一次的利福喷汀和莫西沙星联合方案对小鼠结核分枝杆菌的疗效。
Antimicrob Agents Chemother. 2001 Dec;45(12):3482-6. doi: 10.1128/AAC.45.12.3482-3486.2001.

引用本文的文献

1
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.强化治疗高剂量利福平联合左氧氟沙星与标准治疗成人结核性脑膜炎（TBM-IT）的随机对照试验方案。
Trials. 2011 Feb 2;12:25. doi: 10.1186/1745-6215-12-25.
2
New drugs and regimens for treatment of TB.新型抗结核药物及治疗方案。
Expert Rev Anti Infect Ther. 2010 Jul;8(7):801-13. doi: 10.1586/eri.10.60.

本文引用的文献

1
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.莫西沙星治疗肺结核的早期杀菌活性：一项前瞻性随机研究。
Antimicrob Agents Chemother. 2004 Mar;48(3):780-2. doi: 10.1128/AAC.48.3.780-782.2004.
2
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.莫西沙星在肺结核患者中的杀菌活性。
Am J Respir Crit Care Med. 2003 Dec 1;168(11):1342-5. doi: 10.1164/rccm.200305-682OC. Epub 2003 Aug 13.
3
A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs.一种用于确定抗结核药物比活性的新型替代标志物的多中心比较。
J Antimicrob Chemother. 2003 Sep;52(3):473-6. doi: 10.1093/jac/dkg345. Epub 2003 Jul 29.
4
A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.一种计算抗结核药物早期杀菌活性的迭代方法。
Am J Respir Crit Care Med. 2002 Jul 1;166(1):31-5. doi: 10.1164/rccm.2112077.
5
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.一项抗结核药物早期杀菌活性的多中心研究。
J Antimicrob Chemother. 2000 Jun;45(6):859-70. doi: 10.1093/jac/45.6.859.
6
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis.莫西沙星（BAY12 - 8039），一种新型8 - 甲氧基喹诺酮类药物，在结核病小鼠模型中具有活性。
Antimicrob Agents Chemother. 1999 Jan;43(1):85-9. doi: 10.1128/AAC.43.1.85.
7
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.莫西沙星和克林沙星对结核分枝杆菌的体外及体内活性
Antimicrob Agents Chemother. 1998 Aug;42(8):2066-9. doi: 10.1128/AAC.42.8.2066.
8
Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.异烟肼在肺结核中的早期杀菌活性。方法学优化。DATRI 008研究组。
Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):918-23. doi: 10.1164/ajrccm.156.3.9612016.
9
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.药物在肺结核患者中的早期杀菌活性。
Am Rev Respir Dis. 1980 Jun;121(6):939-49. doi: 10.1164/arrd.1980.121.6.939.

Moxifloxacin treatment of tuberculosis.

作者信息

Gosling Roland, Gillespie Stephen

出版信息

Antimicrob Agents Chemother. 2004 Sep;48(9):3642; author reply 3642-3. doi: 10.1128/AAC.48.9.3642-3643.2004.

DOI:10.1128/AAC.48.9.3642-3643.2004
PMID:15328148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC514750/
Abstract
摘要